Drug Shortage Report for DEPO-MEDROL

Last updated on 2025-02-12

Report ID 232321
Drug Identification Number 00030759
Brand name DEPO-MEDROL 40 MG/ML
Common or Proper name DEPO-MEDROL 40 MG/ML
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) METHYLPREDNISOLONE ACETATE
Strength(s) 40MG
Dosage form(s) SUSPENSION
Route of administration INTRASYNOVIAL INTRAMUSCULAR INTRALESIONAL INTRA-ARTICULAR INTRASYNOVIAL INTRAMUSCULAR INTRALESIONAL INTRA-ARTICULAR
Packaging size 10 X 1ML
Anatomical Therapeutical Chemical (ATC) code H02AB
Anatomical Therapeutical Chemical (ATC) description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2024-11-04
Actual start date
Estimated end date
Actual end date 2025-02-11
Shortage status Resolved
Updated date 2025-02-12
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: [email protected]

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v17 2025-02-12 English Compare
v16 2025-02-11 French Compare
v15 2025-02-11 English Compare
v14 2025-01-22 French Compare
v13 2025-01-22 English Compare
v12 2024-11-05 English Compare
v11 2024-10-02 French Compare
v10 2024-10-02 English Compare
v9 2024-08-28 French Compare
v8 2024-08-28 English Compare
v7 2024-08-21 French Compare
v6 2024-08-21 English Compare
v5 2024-07-25 English Compare
v4 2024-07-24 French Compare
v3 2024-07-24 English Compare
v2 2024-07-05 French Compare
v1 2024-07-05 English Compare

Showing 1 to 17 of 17